CEDRIC TEAMER

Responsible to position Nexavar as a 1st line choice for the treatment for heptocelluar carcinoma also responsible to position Stivarga for combo therapy if patients progressed on Nexavar.

Targeted accounts are academic and community hospitals, Medical

Oncologists, Hematologist and Cancer Clinics. Very active in applicable conferences held in the Maryland,

Northern Virginia and DC Metro areas. Extensive office contacts in the solid tumor market..

Responsible to position Cyramza as a preferred 2nd line choice for the treatment of Advanced Metastatic

Gastric or GEJ Adenocarcinoma, Advanced HCC and Mutated Colorectal Cancer and Non Small Cell Lung Cancer. Responsible to position Erbitux 1st line choice for the treatment of Metastatic Colorectal Cancer as well as Head and Neck Cancer.

Targeted accounts are academic and community hospitals, Medical

Oncologists, Hematologist and Cancer Clinics. Very active in applicable conferences held in the Maryland,

Northern Virginia and DC Metro areas. Extensive office contacts in the solid tumor market..

-Ranked #12/45 2022

-Northeast GPO Liaison

Responsible for the growth of new product Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone, that is the first of a number of product candidates using the DETERx technology.

DETERx can be used with drugs that are commonly abused, such as opioids and amphetamines, as well as drugs with a narrow therapeutic index that would benefit from the protection against misuse, such as crushing, grinding, or dissolving the product.

Calling on Pain Management, Anesthesiology, Physical Medicine & Rehab, Neurology and High-Decile PCPs (FPs/GPs/IMs/PAs).

Responsible for implementing Collegium's sales/marketing plan to assure maximum market penetration.

Syneos/Glenmark Therapeutics –Responsible for the launch of a new company in the US (Glenmark) and product (Otiprio). Otiprio is indicated for the treatment of acute otitis external in patients 6 months of and and older. This product required work with Otolaryngologists (Ear, Nose and Throat). Worked closely through one distribution channel,

specialty pharmacies . "Buy and Bill" product.

Responsible for the promotion of Tuzistra XR (Indicated for relief of cough and symptoms associated with upper respiratory allergies or a common cold) and Moxatag (Indicated for the treatment of tonsillitis and/or pharyngitis secondary to streptococcus pyogenes in adult patients and pediatric patients 12 years and older).

This product required work health care providers such as primary care physicians, family practice physicians in hospital, private office and urgent care facilities.

Responsible for the launch and promotion of Vivlodex (Indicated for OA), Zorvolex (indicated for OA and the management of mild to moderate acute pain) and Tivorbex (indicated for mild to severe acute pain).
These products required work with a broad spectrum of specialist which included primary care, internist, rheumatologist, podiatrist, orthopedic surgeons and other pain specialists.

Responsible for growing sales of Opana ER (Indicated for the management of pain severe enough to require daily, around the clock, long term opioid treatment and for which alternative treatment options are ineffective).
These products work with a wide spectrum of health care providers such as primary care physicians, family practice physicians, pain specialists, podiatrists, neurologist, internist and endocrinologist.

- Nominated to Leadership Development program 2010

- Graduated from LDP 2011

- District Trainer

- Ranked 13/37 Regionally 2012

- Elected to Inventiv Health Sales Representative Advisory Board Nov 2012

- 2011 Elected to Voltaren Gel Regional Advisory Board

Responsible for the Launch and Sales of Lovaza (Omacor) indicated to reduce high triglycerides, DynaCirc CR, and Innopran XL (both indicated for the management of hypertension), Lescol XL (indicated to lower cholesterol) and Antara (indicated for the management of dyslipidemia and hyperlipidemia. Sales calls were made on a broad spectrum of health care providers such cardiologist, nephrologist, endocrinologist, internist and primary care physicians.

-District Trainer From 2007-2008

-Most Memorable District Trainer Presentation award Q3 2007

-100 Lovaza TRX Club Q3 2007

-"DM City" Contest Winner Q1 2007

-Mid Atlantic Personal Best Eagles Club.

Responsible for the sales of Metrogel (indicated for the topical treatment of inflammatory lesions of rosacea), Rosanil (indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis) and Cetaphil Therapeutic Hand Cream.

-Ranked #1 Cetaphil Therapuetic hand cream 2004

- 104% Quota Attainment Metrogel 2004

Responsible for marketing and selling products in the Industrial Markets division to industrial manufacturers, consult with various companies to optimize company's manufacturing process, liaison between distribution and end users, monitored maintain all regional client accounts.

-Top 10% Hero"s award recipient 2001